Online ISSN: 2582-6387
IP Journal of Surgery and Allied Sciences (JSAS) open access, peer-reviewed quarterly journal publishing since 2019 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article ‘Ahead more...Case Report
Author Details :
Volume : 2, Issue : 4, Year : 2020
Article Page : 120-122
https://doi.org/10.18231/j.jsas.2020.021
Abstract
Surgeons are required to keep themselves updated on ever-increasing list of drugs that may influence the outcomes of surgeries, especially in an emergency scenario. Here, we report a case of acute abdomen, wherein the patient was on dabigatran, a ‘Non-vit. K/Direct Oral Anti-Coagulant’ (NOAC/DOAC). NOACs are relatively recent additions to anticoagulation care. In our patient, dabigatran was prescribed by a cardiologist to prevent the occurrence of stroke in the patient who was suffering from atrial fibrillation. In case of uncontrolled bleeding, or when an emergency surgery is needed, the effect of dabigatran can be
reversed with the use of a specific monoclonal antibody – idarucizumab. Knowledge about the drug & its reversal agent, and a multi-disciplinary approach, could make it possible for us to operate on the patient, and avoid excessive bleeding during the surgery.
Keywords: Anticoagulant dabigatran etexilate emergency surgery idarucizumab.
How to cite : Badani R , Kalia A , Valse P , Tilak A , Dahiya A K , Successful emergency surgery in a patient on dabigatran, after reversing the anticoagulation effect using Idarucizumab – A case report. IP J Surg Allied Sci 2020;2(4):120-122
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.